Veenendaal, Netherlands

Eylem Arikan

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eylem Arikan: Innovator in Brachytherapy Technology

Introduction

Eylem Arikan is a notable inventor based in Veenendaal, Netherlands. She has made significant contributions to the field of medical technology, particularly in brachytherapy, which is a form of radiation therapy used to treat cancer. Her innovative work has led to the development of a unique patent that enhances the effectiveness of brachytherapy treatments.

Latest Patents

Eylem Arikan holds a patent for a Modular Brachytherapy Applicator. This exemplary brachytherapy applicator features an interstitial tube with a body that has a proximal end and a distal end. The central conduit extends from the distal end of the body and includes a proximal opening, a distal opening, and a channel that connects them. Notably, the proximal opening is offset from the axis of the body, allowing for improved fluid connection to a brachytherapy guide tube. The channel is designed to accommodate at least one of a needle or a catheter, enhancing the applicator's functionality in clinical settings. She has 1 patent to her name.

Career Highlights

Eylem Arikan is currently employed at Nucletron Operations B.V., where she continues to innovate in the field of brachytherapy. Her work is instrumental in advancing treatment options for cancer patients, showcasing her commitment to improving healthcare through technology.

Collaborations

Throughout her career, Eylem has collaborated with talented professionals, including Jan Willem Van Manen and Wilko Van Erp. These collaborations have fostered an environment of innovation and creativity, contributing to the success of her projects.

Conclusion

Eylem Arikan is a pioneering inventor whose work in brachytherapy technology is making a significant impact in the medical field. Her dedication to innovation and collaboration continues to drive advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…